Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
This study is currently recruiting participants.
Verified November 2013
by Iverson Genetic Diagnostics, Inc.
Study NCT01305148 Information provided by Iverson Genetic Diagnostics, Inc.
First Received on February 25, 2011. Last Updated on November 24, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Warfarin GenoSTAT Test
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Iverson Genetic Diagnostics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers